Skip to content
St Vincent's Centre for Applied Medical Research

John Moore

Prof John Moore is a Haematologist with extensive experience in stem cell transplantation and immunotherapy over 25 years.

Bio

Professor John Moore is a Haematologist with extensive experience in stem cell transplantation and immunotherapy over 25 years. He is the Head of the Cellular Therapies Laboratory within the Haematology AMR Research Program at St Vincent’s Centre for Applied Medical Research. Prof Moore is the clinical lead of the NSW statewide service of stem cell transplantation for autoimmune diseases at St Vincent’s Hospital, which is the largest in Australia and one of the major contributors to the international autoimmune disease transplant database (EBMT registry). He is a Conjoint Professor at UNSW Sydney and has published extensively in the field of stem cell transplantation with over 120 publications.

PublicationsSelected Publications from John Moore

  • A prospective randomised trial comparing CD34 selected versus unmanipulated haemopoietic stem cell transplantation for severe resistant rheumatoid arthritis. Moore J, Brooks P, Milliken S, et al. Arthritis and Rheumatism. 2002; 46:2301-2309. DOI: 10.1002/art.10495. PMID: 12355477.
  • Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. Walker I, Panzarella T, Couban S, et al. Lancet Oncology. 2016; 17(2):164-173. DOI: 10.1016/S1470-2045(15)00462-3. PMID: 26723083.
  • Evolution, trends, outcomes and economics of haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases. Snowden JA, Badoglio M, Labopin M, et al. Blood Advances. 2017; 1:2742-2755. DOI: 10.1182/bloodadvances.2017010041. PMID: 29296926.
  • Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis. Moore JJ, Massey JC, Ford CD, et al. Journal of Neurology, Neurosurgery and Psychiatry. 2019; 90(5):514-521. DOI: 10.1136/jnnp-2018-319446. PMID: 30538138.
  • Graft-versus-host disease prophylaxis with cyclophosphamide and cyclosporin. Curtis DJ, Patil SS, Reynolds J, et al. The New England journal of Medicine. 2025; online ahead of print. DOI:10.1056/NEJMoa2503189. PMID: 40513032.